Literature DB >> 2444328

The prevalence of pain in four cancers.

H P Greenwald1, J J Bonica, M Bergner.   

Abstract

Although pain is widely recognized as a major problem in cancer patients, most studies have concentrated on pain among those with advanced or terminal cancer in specialized treatment settings. The study reported here gives a more complete picture of the problem of pain among cancer patients by providing data generalizable to those in early as well as late stages of the disease, and receiving care in the community as well as specialized treatment centers. Having included measures of several distinct features of pain, this study also provides a more complete understanding of the cancer patient's day-to-day pain problem than earlier investigations. The findings presented here indicate that serious pain may occur in all cancer stages, and often represents an ongoing medical problem. The data suggest that many patients may benefit from earlier and more aggressive use of available antipain treatment methods.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2444328     DOI: 10.1002/1097-0142(19871115)60:10<2563::aid-cncr2820601036>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey.

Authors:  Sebastiano Mercadante; Fausto Roila; Oscar Berretto; Roberto Labianca; Stefania Casilini
Journal:  Support Care Cancer       Date:  2008-05-14       Impact factor: 3.603

2.  Cancer patient attitudes toward analgesic usage and pain intervention.

Authors:  Charles B Simone; Neha Vapiwala; Margaret K Hampshire; James M Metz
Journal:  Clin J Pain       Date:  2012-02       Impact factor: 3.442

Review 3.  Visceral pain from colon and rectum: the mechanotransduction and biomechanics.

Authors:  Bin Feng; Tiantian Guo
Journal:  J Neural Transm (Vienna)       Date:  2019-10-09       Impact factor: 3.575

4.  Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer.

Authors:  Carol M Moinpour; Nancy L Vaught; Bryan Goldman; Mary W Redman; Philip A Philip; Barbara Millwood; Scott M Lippman; Thomas E Seay; Patrick J Flynn; Eileen M O'Reilly; Kendrith M Rowland; Ralph P Wong; Jacqueline Benedetti; Charles D Blanke
Journal:  J Clin Oncol       Date:  2010-07-06       Impact factor: 44.544

5.  Effects of coaching patients with lung cancer to report cancer pain.

Authors:  Diana Wilkie; Donna Berry; Kevin Cain; Hsiu-Ying Huang; Julia Mekwa; Frances Lewis; Betty Gallucci; Yu-Chuan Lin; Angela Chia-Chen Chen; Nai-Ying Ko
Journal:  West J Nurs Res       Date:  2010-02       Impact factor: 1.967

Review 6.  Photodynamic therapy for lung cancer and malignant pleural mesothelioma.

Authors:  Charles B Simone; Keith A Cengel
Journal:  Semin Oncol       Date:  2014-10-07       Impact factor: 4.929

7.  Multicentre study of cancer pain and its treatment in France.

Authors:  F Larue; S M Colleau; L Brasseur; C S Cleeland
Journal:  BMJ       Date:  1995-04-22

8.  Presentation patterns and outcomes of patients with cancer accessing care in emergency departments in Victoria, Australia.

Authors:  Dania M van der Meer; Tracey J Weiland; Jennifer Philip; George A Jelinek; Mark Boughey; Jonathan Knott; Claudia H Marck; Jennifer L Weil; Heather P Lane; Anthony J Dowling; Anne-Maree Kelly
Journal:  Support Care Cancer       Date:  2015-08-26       Impact factor: 3.603

9.  Sensivity to change of the Spanish validated Memorial Pain Assessment Card in cancer patients.

Authors:  Jorge Contreras; Francisco Valcárcel; Manuel Dómine; Yolanda Escobar
Journal:  Clin Transl Oncol       Date:  2008-10       Impact factor: 3.405

10.  Factors associated with pain among ambulatory patients with cancer with advanced disease at a comprehensive cancer center.

Authors:  Sherri O Stuver; Thomas Isaac; Jane C Weeks; Susan Block; Donna L Berry; Roger B Davis; Saul N Weingart
Journal:  J Oncol Pract       Date:  2012-03-06       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.